Polaryx Therapeutics, Inc. PLYX
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | -6.85M | -6.48M | -8.99M | -8.21M | -- |
| Total Depreciation and Amortization | -- | -- | -- | -- | -- |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 632.00K | 741.00K | 4.73M | 4.76M | -- |
| Change in Net Operating Assets | 408.00K | 438.00K | 316.00K | 144.00K | -- |
| Cash from Operations | -5.81M | -5.30M | -3.94M | -3.31M | -- |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | -- | -- |
| Total Debt Issued | -- | -- | -- | 0.00 | -- |
| Total Debt Repaid | -- | -- | -- | 0.00 | -- |
| Issuance of Common Stock | 14.07M | 4.24M | 4.49M | 6.48M | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -27.00K | -27.00K | -27.00K | -156.00K | -- |
| Cash from Financing | 14.05M | 4.22M | 4.47M | 6.33M | -- |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 8.24M | -1.08M | 522.00K | 3.01M | -- |